Foulds G, Knirsch A K, Stankewich J P, Weidler D R
Int J Clin Pharmacol Res. 1985;5(2):79-86.
The kinetics of co-administered ampicillin plus sulbactam were examined at doses being used in clinical trials of this combination of a beta-lactam antibiotic (ampicillin) and a beta-lactamase inhibitor (sulbactam). Following 15-min infusion of 2 g ampicillin plus 1 g sulbactam, peak serum concentrations of 120 micrograms/ml ampicillin and 60 micrograms/ml sulbactam were observed. The half-life was approximately one hour for both drugs. Approximately 75% of the dose of sulbactam and ampicillin was recovered in urine. The data fit a two-compartment pharmacokinetic model. Intramuscular administration of 1 g ampicillin plus 0.5 g sulbactam produced mean peak concentrations of 18 micrograms/ml ampicillin plus 13 micrograms/ml sulbactam. Estimates of variability of the data in normal male subjects are provided to serve as references for clinical trials.
在β-内酰胺抗生素(氨苄西林)与β-内酰胺酶抑制剂(舒巴坦)联合使用的临床试验剂量下,对氨苄西林加舒巴坦联合给药的动力学进行了研究。静脉输注2克氨苄西林加1克舒巴坦15分钟后,观察到氨苄西林的血清峰值浓度为120微克/毫升,舒巴坦为60微克/毫升。两种药物的半衰期均约为1小时。舒巴坦和氨苄西林约75%的剂量经尿液回收。数据符合二室药代动力学模型。肌肉注射1克氨苄西林加0.5克舒巴坦产生的氨苄西林平均峰值浓度为18微克/毫升,舒巴坦为13微克/毫升。提供了正常男性受试者数据变异性的估计值,以供临床试验参考。